The effectiveness of atomoxetine with Ritalin and fluoxetine on anxiety, the severity of attention deficit hyperactivity disorder, and the performance of children with ADHD - Attention Deficit Hyperactivity Disorder

Comparative study of the effectiveness of atomoxetine with Ritalin and fluoxetine on anxiety, the severity of attention deficit hyperactivity disorder and the performance of children with ADHD - Attention Deficit Hyperactivity Disorder

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20211004052670N2

Enrollment

100

Registered

2022-01-19

Start date

2022-02-04

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention Deficit Hyperactivity Disorder and Anxiety Disorders. Attention-deficit hyperactivity disorders + Phobic anxiety disorders

Interventions

Intervention 1: Intervention group 1: Patients in this group are given Ritalin at a dose of 5 mg twice a day (morning and evening) orally and an increase of 10 mg weekly (until clinical response and p

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Students 6 to 12 years old referred to Khorshid Psychiatric Clinic, and Amin Attention Deficit Hyperactivity Disorder and Anxiety Disorder based on DSM-5 Primary age (6 to 12 years)

Exclusion criteria

Exclusion criteria: Having any chronic illness Family history of psychosis and mood disorder in the family first degree

Design outcomes

Primary

Measure	Time frame
Severity of Anxiety Disorders. Timepoint: Before the intervention, 1 and 4 months after the start of the intervention. Method of measurement: The child and parent Screen for Child Anxiety Related Emotional Disorders (SCARED).;Severity of Attention Deficit Hyperactivity Disorder. Timepoint: Before the intervention, 1 and 4 months after the start of the intervention. Method of measurement: Conners' Continuous Performance Test.;Performance score. Timepoint: Before the intervention, 1 and 4 months after the start of the intervention. Method of measurement: The Child Anxiety Impact Scale (CAIS).	—

Measure

Time frame

Severity of Anxiety Disorders. Timepoint: Before the intervention, 1 and 4 months after the start of the intervention. Method of measurement: The child and parent Screen for Child Anxiety Related Emotional Disorders (SCARED).;Severity of Attention Deficit Hyperactivity Disorder. Timepoint: Before the intervention, 1 and 4 months after the start of the intervention. Method of measurement: Conners' Continuous Performance Test.;Performance score. Timepoint: Before the intervention, 1 and 4 months after the start of the intervention. Method of measurement: The Child Anxiety Impact Scale (CAIS).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfsaneh Karbasi Amel

Esfahan University of Medical Sciences

afsanehkarbasi@yahoo.com+98 31 3233 6413

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026